Sport Resolutions

decisions

ITIA v Jessica Eudovic

  • Sport: Tennis
  • Type: Arbitration
  • Issue: Anti-Doping
  • Tribunal: Mark Hovell, Anna Smirnova, Dr Paul Jackson
  • Decision date: 05 November 2026
  • Outcome: 2 years Ineligibility

A decision in the case of the International Tennis Integrity Agency (“ITIA”) against Ms Jessica Eudovic has been issued by the Independent Tribunal.

The decision concerns Ms Eudovic, an American professional tennis player who was 18 years old at the time of testing and in her first year on the professional tour. In the present case, she is bound by the Tennis Anti-Doping Programme 2025 (“TADP 2025”), which governs the substantive rules, while the Tennis Anti-Doping Programme 2026 (“TADP 2026”) governs the procedure.

On 1 October 2025, during the ITF World Tennis Tour W15 event in Santa Tecla, El Salvador (the “Event”), an In-Competition urine sample (the “Sample”) was collected from Ms Eudovic. The Sample was divided into A and B bottles (“A Sample” and “B Sample”) and analysed by a World Anti-Doping Agency (“WADA”) accredited laboratory in Quebec, Canada (the “Laboratory”). The Laboratory’s examination of the A Sample reported an Adverse Analytical Finding (“AAF”) for metabolites of Clostebol, including M1 at an estimated concentration of approximately 0.07 ng/mL, together with M3. Clostebol is an Anabolic Androgenic Steroid and a non-Specified Substance prohibited at all times under S1.1 of the WADA Prohibited List 2025. Ms Eudovic held no applicable Therapeutic Use Exemption, and analysis of the B Sample confirmed the findings. On 21 November 2025, the ITIA notified Ms Eudovic of the AAF and imposed a Provisional Suspension. On 18 December 2025, it charged her with Anti-Doping Rule Violations (“ADRVs”) under Articles 2.1 and/or 2.2 of the TADP, namely the Presence and/or Use of a Prohibited Substance.

On 14 May 2026, following her rejection of the sanction proposed by the ITIA, Ms Eudovic requested a hearing before an Independent Tribunal in accordance with Article 8.2 of the TADP 2026. On 22 May 2026, the Chair of the Independent Panel appointed Mr Mark Hovell as Chair of the Independent Tribunal, and on 15 July 2026 Ms Anna Smirnova and Dr Paul Jackson were confirmed as the remaining members.

A hearing took place on 6 and 14 October 2026. Ms Eudovic admitted the ADRVs on the basis of strict liability and did not challenge the Laboratory’s analysis, so the issues were source, intention, Fault and a claim that the ITIA had breached a duty of care. The ITIA sought a four-year period of Ineligibility under Article 10.2.1.1 of the TADP, submitting that she had established neither how Clostebol entered her system nor that the ADRVs were not intentional, and that the route to proving non-intentionality without source is exceptionally narrow. Ms Eudovic, who was represented pro bono, argued primarily that she had been inadvertently contaminated at the Event and, alternatively, that non-intentionality could be established without proof of source. She sought elimination or reduction of any sanction for No Fault or Negligence or No Significant Fault or Negligence, relying on the very low concentration, negative hair analyses of herself and her father, and expert evidence. The ITIA relied on its own expert, who accepted that dermal exposure was more likely but maintained that the analytical profile could not distinguish cross-contamination from direct topical use.

The Independent Tribunal held that Ms Eudovic had not established source on the balance of probabilities. It attached weight to the negative results of 22 other Players tested at the Event, the absence of any evidence that a Clostebol product was present or used there, and her inability to identify a person, product or occasion of transfer. It distinguished the contaminated meat cases on which she relied, where the evidence had been considerably more extensive, while acknowledging the difficulty of obtaining the assistance of Event personnel.

The Independent Tribunal nevertheless accepted, as the ITIA did not dispute, that proof of source is not a prerequisite to establishing that an ADRV was not intentional within the meaning of Article 10.2.3 of the TADP, while recognising that this is a narrow route and considerably harder where source cannot be shown. It assessed the evidence cumulatively, beginning with the science, taking a broad view, testing the emerging conclusion against common sense and finally considering credibility, and declined to confine the relevant science to controlled studies, as the ITIA had contended. The low concentration and metabolite profile supported dermal exposure, and the experts agreed that Clostebol is not used to enhance sporting performance. The negative hair analyses, treated with caution in light of the chain of custody and the reservations of the ITIA’s expert, were taken principally to weigh against substantial or repeated exposure. The 22 negative samples weighed against Ms Eudovic’s case but did not exclude an isolated exposure. A single deliberate or therapeutic application could not be scientifically excluded, but was found unlikely in the absence of evidence of any injury or need for treatment, whereas the regional contamination risk acknowledged in the ITIA’s own “Caution: Clostebol” guidance provided a context in which inadvertent exposure was credible. Having regard to the caution required in assessing any Player’s account, the Independent Tribunal found Ms Eudovic’s evidence consistent and truthful, and gave weight to her age, inexperience and the unremarkable nature of her conduct. It concluded that non-intentional exposure was more likely than not, a positive inference from the evidence as a whole rather than from the mere absence of proof of deliberate doping.

As the ADRVs were found not to be intentional, the applicable period of Ineligibility was a maximum of two years under Article 10.2.2 of the TADP. Because source was not established, and the definitions of No Fault or Negligence and No Significant Fault or Negligence in Appendix One to the TADP require the Player to establish how the Prohibited Substance entered her system, the Independent Tribunal could not assess Fault under Articles 10.5 and 10.6 of the TADP, and no reduction was available. It also held that it lacked jurisdiction over the duty of care claim, which falls to the English courts under Article 1.1.5 of the TADP.

Ms Eudovic was found to have committed ADRVs under Articles 2.1 and 2.2 of the TADP and was sanctioned with a period of Ineligibility of two (2) years, with credit under Article 10.13.2 of the TADP for her Provisional Suspension, ending at midnight on 20 November 2027. Her results at the Event were Disqualified under Article 10.10 of the TADP, with forfeiture of any medals, points and prizes.

Sport Resolutions is the independent secretariat to the International Tennis Integrity Agency’s Independent Panel.

A copy of the full decision can be accessed via the related links tab on the right-hand side.

Related Documents

Notice

Email service update